Sellas Stock Based Compensation from 2010 to 2026

SLS Stock

USD 3.59 0.04 1.13%

Sellas Life Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2026. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2007-06-30

Previous Quarter

501 K

Current Value

503 K

Quarterly Volatility

443.9 K

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Sellas Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sellas Life's main balance sheet or income statement drivers, such as Interest Expense of 806.9 K, Other Operating Expenses of 29.6 M or Research Development of 16.8 M, as well as many indicators such as Price To Sales Ratio of 50.01, Dividend Yield of 0.0335 or PTB Ratio of 7.35. Sellas financial statements analysis is a perfect complement when working with Sellas Life Valuation or Volatility modules.

Build AI portfolio with Sellas Stock

Check out the analysis of Sellas Life Correlation against competitors.

The evolution of Stock Based Compensation for Sellas Life Sciences provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Sellas Life compares to historical norms and industry peers.

Latest Sellas Life's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Sellas Life Sciences over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Sellas Life's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sellas Life's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Sellas Stock Based Compensation Regression Statistics

	Arithmetic Mean	1,999,667
	Geometric Mean	1,626,520
	Coefficient Of Variation	64.37
	Mean Deviation	962,000
	Median	1,726,000
	Standard Deviation	1,287,275
	Sample Variance	1.7T
	Range	5M
	R-Value	(0.53)
	Mean Square Error	1.3T
	R-Squared	0.28
	Significance	0.03
	Slope	(134,804)
	Total Sum of Squares	26.5T

Sellas Stock Based Compensation History

	2026	1.8 M
	2025	1.4 M
	2024	1.6 M
	2023	1.4 M
	2022	1.7 M
	2021	1 M
	2020	578 K

Other Fundumenentals of Sellas Life Sciences

Stock Based Compensation To Revenue

Sellas Life Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Current Assets	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Common Stock	Current Deferred Revenue	Short Term Debt	Net Tangible Assets	Good Will	Long Term Debt Total	Capital Surpluse	Intangible Assets	Property Plant Equipment	Long Term Debt	Deferred Long Term Liab	Net Receivables	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.61	-0.57	0.91	-0.44	-0.21	-0.34	0.89	0.8	0.66	0.45	0.06	0.63	0.7	0.73	0.77	-0.25	0.69	0.44	0.46	0.02	0.4	-0.31	-0.3
Total Stockholder Equity	0.61		-0.45	0.56	-0.27	-0.35	-0.2	0.21	0.5	0.24	0.3	0.75	0.37	0.16	0.55	0.45	-0.19	0.12	0.08	0.03	0.08	0.64	0.17	-0.18
Net Debt	-0.57	-0.45		-0.75	0.16	0.36	0.19	-0.46	-0.28	-0.27	0.33	-0.28	-0.25	-0.27	-0.27	-0.13	-0.24	-0.29	-0.16	-0.32	0.29	-0.48	-0.28	0.17
Total Current Assets	0.91	0.56	-0.75		-0.5	-0.26	-0.35	0.81	0.72	0.6	0.33	0.07	0.48	0.67	0.7	0.49	-0.03	0.71	0.43	0.53	0.13	0.49	-0.06	-0.22
Retained Earnings	-0.44	-0.27	0.16	-0.5		0.22	0.57	-0.36	-0.71	-0.44	-0.4	-0.08	-0.07	-0.67	-0.81	-0.21	-0.36	-0.68	0.05	-0.27	-0.6	0.2	0.0	-0.34
Accounts Payable	-0.21	-0.35	0.36	-0.26	0.22		-0.39	-0.07	-0.44	-0.15	0.08	-0.49	-0.59	-0.04	-0.44	-0.16	-0.05	-0.11	-0.43	-0.29	0.07	-0.15	0.07	0.06
Short Term Investments	-0.34	-0.2	0.19	-0.35	0.57	-0.39		-0.28	-0.22	-0.27	-0.21	0.07	0.42	-0.57	-0.33	-0.03	-0.21	-0.48	0.46	0.06	-0.46	0.1	-0.3	-0.19
Total Liab	0.89	0.21	-0.46	0.81	-0.36	-0.07	-0.28		0.72	0.69	0.41	-0.32	0.59	0.74	0.6	0.73	-0.28	0.74	0.53	0.56	-0.07	0.17	-0.5	-0.37
Common Stock	0.8	0.5	-0.28	0.72	-0.71	-0.44	-0.22	0.72		0.63	0.57	0.1	0.68	0.61	0.88	0.68	-0.21	0.66	0.52	0.52	0.24	0.09	-0.46	-0.06
Current Deferred Revenue	0.66	0.24	-0.27	0.6	-0.44	-0.15	-0.27	0.69	0.63		0.25	-0.09	0.37	0.58	0.65	0.57	-0.22	0.8	0.22	0.82	0.14	0.13	-0.25	-0.21
Short Term Debt	0.45	0.3	0.33	0.33	-0.4	0.08	-0.21	0.41	0.57	0.25		-0.1	0.33	0.47	0.61	0.47	-0.44	0.39	0.39	0.06	0.6	0.12	-0.4	-0.23
Net Tangible Assets	0.06	0.75	-0.28	0.07	-0.08	-0.49	0.07	-0.32	0.1	-0.09	-0.1		0.12	-0.3	0.26	0.01	0.01	-0.3	-0.14	-0.15	-0.01	0.33	0.34	-0.14
Good Will	0.63	0.37	-0.25	0.48	-0.07	-0.59	0.42	0.59	0.68	0.37	0.33	0.12		0.17	0.48	0.71	-0.46	0.24	0.84	0.46	-0.3	0.23	-0.69	-0.39
Long Term Debt Total	0.7	0.16	-0.27	0.67	-0.67	-0.04	-0.57	0.74	0.61	0.58	0.47	-0.3	0.17		0.7	0.5	0.12	0.9	0.08	0.26	0.39	0.03	-0.1	0.02
Capital Surpluse	0.73	0.55	-0.27	0.7	-0.81	-0.44	-0.33	0.6	0.88	0.65	0.61	0.26	0.48	0.7		0.57	-0.05	0.72	0.31	0.44	0.46	0.13	-0.21	-0.15
Intangible Assets	0.77	0.45	-0.13	0.49	-0.21	-0.16	-0.03	0.73	0.68	0.57	0.47	0.01	0.71	0.5	0.57		-0.47	0.42	0.37	0.27	-0.24	0.19	-0.6	-0.4
Property Plant Equipment	-0.25	-0.19	-0.24	-0.03	-0.36	-0.05	-0.21	-0.28	-0.21	-0.22	-0.44	0.01	-0.46	0.12	-0.05	-0.47		0.09	-0.49	-0.17	0.15	-0.11	0.6	0.52
Long Term Debt	0.69	0.12	-0.29	0.71	-0.68	-0.11	-0.48	0.74	0.66	0.8	0.39	-0.3	0.24	0.9	0.72	0.42	0.09		0.18	0.61	0.43	0.03	-0.14	0.05
Deferred Long Term Liab	0.44	0.08	-0.16	0.43	0.05	-0.43	0.46	0.53	0.52	0.22	0.39	-0.14	0.84	0.08	0.31	0.37	-0.49	0.18		0.5	-0.11	0.22	-0.65	-0.41
Net Receivables	0.46	0.03	-0.32	0.53	-0.27	-0.29	0.06	0.56	0.52	0.82	0.06	-0.15	0.46	0.26	0.44	0.27	-0.17	0.61	0.5		0.04	0.12	-0.31	-0.2
Short Long Term Debt	0.02	0.08	0.29	0.13	-0.6	0.07	-0.46	-0.07	0.24	0.14	0.6	-0.01	-0.3	0.39	0.46	-0.24	0.15	0.43	-0.11	0.04		-0.09	0.23	0.27
Net Invested Capital	0.4	0.64	-0.48	0.49	0.2	-0.15	0.1	0.17	0.09	0.13	0.12	0.33	0.23	0.03	0.13	0.19	-0.11	0.03	0.22	0.12	-0.09		0.38	-0.33
Net Working Capital	-0.31	0.17	-0.28	-0.06	0.0	0.07	-0.3	-0.5	-0.46	-0.25	-0.4	0.34	-0.69	-0.1	-0.21	-0.6	0.6	-0.14	-0.65	-0.31	0.23	0.38		0.29
Capital Stock	-0.3	-0.18	0.17	-0.22	-0.34	0.06	-0.19	-0.37	-0.06	-0.21	-0.23	-0.14	-0.39	0.02	-0.15	-0.4	0.52	0.05	-0.41	-0.2	0.27	-0.33	0.29

Click cells to compare fundamentals

About Sellas Life Financial Statements

Sellas Life shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Sellas Life investors may analyze each financial statement separately, they are all interrelated. The changes in Sellas Life's assets and liabilities, for example, are also reflected in the revenues and expenses on on Sellas Life's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	1.4 M	1.8 M
Stock Based Compensation To Revenue	1.55	1.63

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Sellas Stock Based Compensation from 2010 to 2026

Latest Sellas Life's Stock Based Compensation Growth Pattern

Sellas Stock Based Compensation Regression Statistics

Sellas Stock Based Compensation History

Other Fundumenentals of Sellas Life Sciences

Sellas Life Stock Based Compensation component correlations

About Sellas Life Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Sellas Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY